Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb buy fenjal

Start price
€41.54
18.04.19 / 50%
Target price
€52.32
09.06.20
Performance (%)
30.00%
End price
€54.00
09.06.20
Summary
This prediction ended on 09.06.20 with a price of €54.00. The BUY prediction by fenjal for Bristol-Myers Squibb saw massive gains of 30.00%. Dividends of €1.60 are taken into consideration when calculating the performance. fenjal has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Bristol-Myers Squibb 1.908% 1.908% -28.529% -16.263%
iShares Core DAX® 1.804% -0.748% 13.168% 16.408%
iShares Nasdaq 100 -0.182% -3.412% 39.976% 43.502%
iShares Nikkei 225® 0.413% -7.381% 18.776% 2.874%
iShares S&P 500 0.664% -1.941% 28.141% 42.155%

According to fenjal what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Cons

Comments by fenjal for this prediction

In the thread Bristol-Myers Squibb diskutieren
Prediction Buy
Perf. (%) 30.00%
Target price 52.316
Change
Ends at 09.06.20

fenjal stimmt dem Sentiment von 'Buy' zu

fenjal stimmt am 18.04.2019 dem Buy-Gesamtsentiment mit dem Kursziel 60.4$ zu.

In the thread Trading Bristol-Myers Squibb
Prediction Buy
Perf. (%) 30.00%
Target price 52.316
Change
Ends at 09.06.20

Buy beendet

Stopped prediction by fenjal for Bristol-Myers Squibb

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€47.60
05.01.24
-
05.01.25
0.63%
05.03.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€68.08
03.01.23
-
03.01.24
-32.29%
28.12.23

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€66.35
25.03.22
-
25.04.22
6.07%
26.04.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€49.48
19.06.20
€55.00
04.11.21
12.05%
04.04.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating